Clinical Trials in Bern, Switzerland
433 recruiting
Showing 1–20 of 451 trials
Recruiting
Not Applicable
Questionnaire on Congenital Cancer Signs Through Self-Assessment
Pediatric CancerHereditary Cancer SyndromesCancer Predisposition Syndromes+1 more
Insel Gruppe AG, University Hospital Bern205 enrolled1 locationNCT07378423
Recruiting
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
FatigueMultiple SclerosisHypogammaglobulinemia
Insel Gruppe AG, University Hospital Bern106 enrolled1 locationNCT05357781
Recruiting
Phase 1Phase 2
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
GIST
Deciphera Pharmaceuticals, LLC94 enrolled25 locationsNCT05957367
Recruiting
Phase 3
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Ovarian CancerOvarian Neoplasms
Merck Sharp & Dohme LLC900 enrolled28 locationsNCT07318558
Recruiting
Not Applicable
Optimization of Transcranial Motor Evoked Potentials in Supratentorial Surgeries
Surgery
Insel Gruppe AG, University Hospital Bern203 enrolled1 locationNCT06480370
Recruiting
Phase 2
A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
Giant Cell Arteritis
Insel Gruppe AG, University Hospital Bern70 enrolled1 locationNCT06335888
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC686 enrolled240 locationsNCT06459180
Recruiting
Not Applicable
Brain Circuitry Changes in Central Poststroke Pain: a Clinical and Neuroimaging Study
PainCPP
Insel Gruppe AG, University Hospital Bern88 enrolled1 locationNCT05335668
Recruiting
International (Pediatric) Peritoneal Biobank
HealthyKidney Failure, ChronicTransplantation+1 more
Heidelberg University500 enrolled26 locationsNCT01893710
Recruiting
Phase 2Phase 3
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb470 enrolled279 locationsNCT07076121
Recruiting
Not Applicable
Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage
Critical IllnessSubarachnoid HemorrhageInfusion Fluid+1 more
Insel Gruppe AG, University Hospital Bern320 enrolled3 locationsNCT04043598
Recruiting
Phase 2Phase 3
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Prostate Cancer
Novartis Pharmaceuticals443 enrolled72 locationsNCT06780670
Recruiting
Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary Biliary Cholangitis
Gilead Sciences318 enrolled196 locationsNCT06051617
Recruiting
Phase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals360 enrolled99 locationsNCT06846281
Recruiting
Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome
Post-Acute COVID-19 Vaccination SyndromePostviral Fatigue
University of Bern200 enrolled1 locationNCT07400848
Recruiting
Phase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Boehringer Ingelheim1,800 enrolled524 locationsNCT06632444
Recruiting
Phase 3
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Leukemia
Daiichi Sankyo700 enrolled288 locationsNCT06578247
Recruiting
Bleeding of Unknown Cause: a Swiss Case-control Study
Bleeding Disorder
University Hospital, Geneva400 enrolled7 locationsNCT05713734
Recruiting
Not Applicable
Non-Invasive Monitoring Of Metabolite Levels Using Novel And Adapted MR Spectroscopy Techniques
Magnetic Resonance Spectroscopy
Insel Gruppe AG, University Hospital Bern100 enrolled1 locationNCT05165537
Recruiting
Not Applicable
Neurofeedback-based Visual Restoration Therapy
Visual Field Defect Homonymous Bilateral
Adrian Guggisberg14 enrolled2 locationsNCT07237412